"Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Finding safe and effective treatment strategies for patients with TP53 -mutated acute myeloid leukemia (AML) remains an important unmet need. Click to show full abstract

Finding safe and effective treatment strategies for patients with TP53 -mutated acute myeloid leukemia (AML) remains an important unmet need.

Keywords: mutated aml; older patients; patients tp53; pevonedistat azacitidine; tp53 mutated; azacitidine older

Journal Title: Blood Advances
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended